Subscription Cancer News
* Mandatory fieldsJanuary 21, 2020
Long‐term oncological and functional follow‐up in low dose rate brachytherapy (LDR‐BT) for prostate cancer: results from the prospective nation‐wide Swiss Registry
Objective: To evaluate the long‐term oncological, functional and toxicity outcomes of LDR‐BT in relation to risk factors and radiation dose in a prospective multicenter cohort...
January 19, 2020
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
Intermediate-risk prostate cancer patients represent the largest of the risk groups and comprise a heterogeneous population of patients with variable prognoses...
January 14, 2020
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
Question: What are the comparative harms of contemporary treatments for localized prostate cancer through 5 years?...
Search in Cancer News
GEC-ESTRO Brachytherapy Guidelines:
ABS Brachytherapy Guidelines and Consensus Statements:
